These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 10639565)

  • 41. Cell-cycle progression is not essential for c-Myc to block differentiation.
    Ryan KM; Birnie GD
    Oncogene; 1997 Jun; 14(23):2835-43. PubMed ID: 9190900
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of ornithine decarboxylase in breast cancer.
    Deng W; Jiang X; Mei Y; Sun J; Ma R; Liu X; Sun H; Tian H; Sun X
    Acta Biochim Biophys Sin (Shanghai); 2008 Mar; 40(3):235-43. PubMed ID: 18330478
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Involvement of Myc targets in c-myc and N-myc induced human tumors.
    Ben-Yosef T; Yanuka O; Halle D; Benvenisty N
    Oncogene; 1998 Jul; 17(2):165-71. PubMed ID: 9674700
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Depletion of polyamines and increase of transforming growth factor-beta1, c-myc, collagen-type I, matrix metalloproteinase-1, and metalloproteinase-2 mRNA in primary human gingival fibroblasts.
    Stabellini G; Moscheni C; Gagliano N; Dellavia C; Calastrini C; Ferioli ME; Gioia M
    J Periodontol; 2005 Mar; 76(3):443-9. PubMed ID: 15857080
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Increased levels of phorbin, c-myc, and ornithine decarboxylase RNAs in human colon cancer.
    Guillem JG; Levy MF; Hsieh LL; Johnson MD; LoGerfo P; Forde KA; Weinstein IB
    Mol Carcinog; 1990; 3(2):68-74. PubMed ID: 1693276
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Regulation of ornithine decarboxylase gene expression in normal and transformed hamster embryo fibroblasts following stimulation by 12-O-tetradecanoylphorbol-13-acetate.
    Gilmour SK; O'Brien TG
    Carcinogenesis; 1989 Jan; 10(1):157-62. PubMed ID: 2642750
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A retro-inverso peptide homologous to helix 1 of c-Myc is a potent and specific inhibitor of proliferation in different cellular systems.
    Pescarolo MP; Bagnasco L; Malacarne D; Melchiori A; Valente P; Millo E; Bruno S; Basso S; Parodi S
    FASEB J; 2001 Jan; 15(1):31-33. PubMed ID: 11099487
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expression and localization of ornithine decarboxylase in reversible papillomatosis induced by uracil in rat bladder.
    Takada N; Yano Y; Otori K; Otani S; Nomura S; Kitamura Y; Fukushima S
    Jpn J Cancer Res; 1998 Apr; 89(4):377-84. PubMed ID: 9617342
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A quantitative reverse transcription and polymerase chain reaction assay for human IGF-II allows direct comparison of IGF-II mRNA levels in cancerous breast, bladder, and prostate tissues.
    Fichera E; Liang S; Xu Z; Guo N; Mineo R; Fujita-Yamaguchi Y
    Growth Horm IGF Res; 2000 Apr; 10(2):61-70. PubMed ID: 10931743
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Regulation of ornithine decarboxylase during oncogenic transformation: mechanisms and therapeutic potential.
    Shantz LM; Levin VA
    Amino Acids; 2007 Aug; 33(2):213-23. PubMed ID: 17443268
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Quantitative and spatial measurements of telomerase reverse transcriptase expression within normal and malignant human breast tissues.
    Hines WC; Fajardo AM; Joste NE; Bisoffi M; Griffith JK
    Mol Cancer Res; 2005 Sep; 3(9):503-9. PubMed ID: 16179497
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Protein kinase C-mediated in vitro invasion of human glioma cells through extracellular-signal-regulated kinase and ornithine decarboxylase.
    da Rocha AB; Mans DR; Lenz G; Fernandes AK; de Lima C; Monteiro VF; Gonçalves D; Moreira JC; Brunetto AL; Rodnight R; Schwartsmann G
    Pathobiology; 2000; 68(3):113-23. PubMed ID: 11174068
    [TBL] [Abstract][Full Text] [Related]  

  • 53. c-Myc exerts a protective function through ornithine decarboxylase against cellular insults.
    Park JK; Chung YM; Kang S; Kim JU; Kim YT; Kim HJ; Kim YH; Kim JS; Yoo YD
    Mol Pharmacol; 2002 Dec; 62(6):1400-8. PubMed ID: 12435808
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tumor progression is accompanied by significant changes in the levels of expression of polyamine metabolism regulatory genes and clusterin (sulfated glycoprotein 2) in human prostate cancer specimens.
    Bettuzzi S; Davalli P; Astancolle S; Carani C; Madeo B; Tampieri A; Corti A
    Cancer Res; 2000 Jan; 60(1):28-34. PubMed ID: 10646846
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Regulation of human ornithine decarboxylase expression following prolonged quiescence: role for the c-Myc/Max protein complex.
    Peña A; Wu S; Hickok NJ; Soprano DR; Soprano KJ
    J Cell Physiol; 1995 Feb; 162(2):234-45. PubMed ID: 7822433
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Posttranscriptional regulation of ornithine decarboxylase activity.
    Dircks L; Grens A; Slezynger TC; Scheffler IE
    J Cell Physiol; 1986 Mar; 126(3):371-8. PubMed ID: 3081524
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Modulation by phenylacetate of early estrogen-mediated events in MCF-7 breast cancer cells.
    Liu J; Li J; Sidell N
    Cancer Chemother Pharmacol; 2007 Feb; 59(2):217-25. PubMed ID: 16738884
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of vasoactive intestinal peptide on adenosine 3',5'-monophosphate, ornithine decarboxylase, and cell growth in a human colon cell line.
    Yu D; Seitz PK; Selvanayagam P; Rajaraman S; Townsend CM; Cooper CW
    Endocrinology; 1992 Sep; 131(3):1188-94. PubMed ID: 1324153
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cisplatin up-regulates the in vivo biosynthesis and degradation of renal polyamines and c-Myc expression.
    Stachurska A; Dudkowska M; Czopek A; Manteuffel-Cymborowska M; Grzelakowska-Sztabert B
    Biochim Biophys Acta; 2004 Aug; 1689(3):259-66. PubMed ID: 15276653
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Detection of bone marrow-disseminated breast cancer cells using an RT-PCR assay of MUC5B mRNA.
    Berois N; Varangot M; Sóñora C; Zarantonelli L; Pressa C; Laviña R; Rodríguez JL; Delgado F; Porchet N; Aubert JP; Osinaga E
    Int J Cancer; 2003 Feb; 103(4):550-5. PubMed ID: 12478674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.